ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,765, issued on Aug. 12, was assigned to H. Lundbeck A/S (Valby, Denmark).
"Catecholamine prodrugs for use in the treatment of Parkinson's Disease" was invented by Morten Jorgensen (Valby, Denmark), Martin Juhl (Valby, Denmark), Klaus Gjervig Jensen (Valby, Denmark) and Lisbet Kvaerno (Valby, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of formula (Id) that are prodrugs of catecholamine for use in treatment of neurodegenerative diseases and disorders. The present invention also provides pharmaceutical compositions comprising compounds of the invention and methods of treating neurodegenerative or neur...